Patents by Inventor Tetsuya Kamataki

Tetsuya Kamataki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040073958
    Abstract: An object of the present invention is to provide a transgenic animal which is useful in a test for forecasting fetal toxicity and teratogenicity of drugs. The present invention provides a transgenic non-human animal or a part thereof wherein several foreign (human-type) proteins which are involved in the drug metabolism or mutant proteins thereof are expressed in the body; a recombinant gene which is useful for the production of said non-human animal; and a method for screening a substance having fetal toxicity and teratogenicity using said non-human animal.
    Type: Application
    Filed: September 11, 2003
    Publication date: April 15, 2004
    Inventors: Motoya Katsuki, Tetsuya Kamataki, Yutaka Teranishi, Mitsuyoshi Ishida, Minoru Kato
  • Patent number: 6660478
    Abstract: There are provided a method of determining a genotype of CYP2A6 gene on the basis of a difference in gene structures of a wild-type gene of CYP2A6 and at least one kind of mutant-type gene associated with mutation of CYP2A6 gene; the method mentioned above, wherein one kind of mutant-type gene associated with mutation of CYP2A6 gene is used, and the mutant-type gene is conversion-type CYP2A6 gene comprising the nucleotide sequence of SEQ ID NO: 4; the method mentioned above, wherein homozygous deletion and heterozygous deletion of CYP2A6 gene are determined by using at least two kinds of mutant-type genes associated with mutation of CYP2A6 gene; a method of determining a genotype of a CYP gene, characterized by carrying out a method comprising the method mentioned above to determine the genotype of the CYP gene; a diagnostic kit for determining a genotype of CYP2A6 gene, comprising 5′-primer capable of hybridizing to both exon 8 of CYP2A6 gene and exon 8 of CYP2A 7 gene, 3′-primer capable of speci
    Type: Grant
    Filed: October 25, 2001
    Date of Patent: December 9, 2003
    Assignee: Sumitomo Pharmaceuticals Company, Limited
    Inventor: Tetsuya Kamataki
  • Patent number: 5447719
    Abstract: A .beta.-glucuronidase inhibitor comprising at least one compound selected from the group consisting of baicalin, oroxylin A-7-O-glucuronide and luteolin-3'-glucuronide; an extract of scutellaria root (baikal skullcap; Scutellariae Radix) and/or schizonepeta spike (Japanese catnip; Schizonepelae Spica); or a Chinese and Japanese traditional prescription comprised of scutellaria root (baikal skullcap; Scutellariae Radix) and/or schizonepeta spike (Japanese catnip; Schizonepelae Spica) as a crude drug. The .beta.
    Type: Grant
    Filed: March 25, 1993
    Date of Patent: September 5, 1995
    Assignee: Tsumura & Co.
    Inventor: Tetsuya Kamataki